248 related articles for article (PubMed ID: 34045511)
41. Estrogen receptors are linked to angiotensin-converting enzyme 2 (ACE2), ADAM metallopeptidase domain 17 (ADAM-17), and transmembrane protease serine 2 (TMPRSS2) expression in the human atrium: insights into COVID-19.
Wang H; Sun X; L VonCannon J; Kon ND; Ferrario CM; Groban L
Hypertens Res; 2021 Jul; 44(7):882-884. PubMed ID: 33536584
[No Abstract] [Full Text] [Related]
42. Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells.
Hernandez JJ; Beaty DE; Fruhwirth LL; Lopes Chaves AP; Riordan NH
J Transl Med; 2021 Apr; 19(1):149. PubMed ID: 33853637
[TBL] [Abstract][Full Text] [Related]
43. TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation.
Mounir Z; Lin F; Lin VG; Korn JM; Yu Y; Valdez R; Aina OH; Buchwalter G; Jaffe AB; Korpal M; Zhu P; Brown M; Cardiff RD; Rocnik JL; Yang Y; Pagliarini R
Oncogene; 2015 Jul; 34(29):3815-25. PubMed ID: 25263440
[TBL] [Abstract][Full Text] [Related]
44. Preclinical pharmacology of FL442, a novel nonsteroidal androgen receptor modulator.
Poutiainen PK; Huhtala T; Jääskeläinen T; Petsalo A; Küblbeck J; Kaikkonen S; Palvimo JJ; Raunio H; Närvänen A; Peräkylä M; Juvonen RO; Honkakoski P; Laatikainen R; Pulkkinen JT
Mol Cell Endocrinol; 2014 Apr; 387(1-2):8-18. PubMed ID: 24565895
[TBL] [Abstract][Full Text] [Related]
45. Androgen sensitivity gateway to COVID-19 disease severity.
Wambier CG; Goren A; Vaño-Galván S; Ramos PM; Ossimetha A; Nau G; Herrera S; McCoy J
Drug Dev Res; 2020 Nov; 81(7):771-776. PubMed ID: 32412125
[TBL] [Abstract][Full Text] [Related]
46. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
Li Y; Xu Q; Ma L; Wu D; Gao J; Chen G; Li H
J Cell Mol Med; 2020 Aug; 24(16):9478-9482. PubMed ID: 32639084
[TBL] [Abstract][Full Text] [Related]
47. Gene expression network analysis provides potential targets against SARS-CoV-2.
Hernández Cordero AI; Li X; Yang CX; Milne S; Bossé Y; Joubert P; Timens W; van den Berge M; Nickle D; Hao K; Sin DD
Sci Rep; 2020 Dec; 10(1):21863. PubMed ID: 33318519
[TBL] [Abstract][Full Text] [Related]
48. ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review.
Lechien JR; Radulesco T; Calvo-Henriquez C; Chiesa-Estomba CM; Hans S; Barillari MR; Cammaroto G; Descamps G; Hsieh J; Vaira L; De Riu G; Sowerby L; Gengler I; Michel J; Saussez S
Head Neck Pathol; 2021 Mar; 15(1):225-235. PubMed ID: 32816230
[TBL] [Abstract][Full Text] [Related]
49. Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data.
Lamy PJ; Rébillard X; Vacherot F; de la Taille A
World J Urol; 2021 Aug; 39(8):3121-3123. PubMed ID: 32488360
[No Abstract] [Full Text] [Related]
50. Increased placental expression of angiotensin-converting enzyme 2, the receptor of SARS-CoV-2, associated with hypoxia in twin anemia-polycythemia sequence (TAPS).
Mao Q; Chu S; Shapiro S; Bliss JM; De Paepe ME
Placenta; 2021 Feb; 105():7-13. PubMed ID: 33497931
[TBL] [Abstract][Full Text] [Related]
51. Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19.
Deng Q; Rasool RU; Russell RM; Natesan R; Asangani IA
iScience; 2021 Mar; 24(3):102254. PubMed ID: 33681723
[TBL] [Abstract][Full Text] [Related]
52. A Plausible Link of TMPRSS2/ACE2/AR Signaling to Male Mortality during the COVID-19 Pandemic in the United States.
Wong LM; Jiang G
Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832534
[TBL] [Abstract][Full Text] [Related]
53. Cross Talk between COVID-19 and Breast Cancer.
Parmar HS; Nayak A; Gavel PK; Jha HC; Bhagwat S; Sharma R
Curr Cancer Drug Targets; 2021; 21(7):575-600. PubMed ID: 33593260
[TBL] [Abstract][Full Text] [Related]
54. Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes.
Elliott A; Saul M; Zeng J; Marshall JL; Kim ES; Nagasaka M; Lenz HJ; Schwartzberg L; Spetzler D; Abraham J; Xiu J; Stafford P; Michael Korn W
Sci Rep; 2021 Mar; 11(1):5639. PubMed ID: 33707526
[TBL] [Abstract][Full Text] [Related]
55. Sex differences in COVID-19: the role of androgens in disease severity and progression.
Mohamed MS; Moulin TC; Schiöth HB
Endocrine; 2021 Jan; 71(1):3-8. PubMed ID: 33179220
[TBL] [Abstract][Full Text] [Related]
56. Androgens' Role in Severity and Mortality Rates of COVID-19.
Ataei A; Derakhshan MM; Razmjooie M; Zare F; Amiresmaeili H; Salehi N; Namakkoobi N; Mirhosseini H; Karim B; Iravani S
Horm Metab Res; 2022 Dec; 54(12):813-826. PubMed ID: 36195265
[TBL] [Abstract][Full Text] [Related]
57. Are sex discordant outcomes in COVID-19 related to sex hormones?
Strope JD; Chau CH; Figg WD
Semin Oncol; 2020 Oct; 47(5):335-340. PubMed ID: 32660890
[TBL] [Abstract][Full Text] [Related]
58. Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer.
Cattrini C; Bersanelli M; Latocca MM; Conte B; Vallome G; Boccardo F
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824674
[TBL] [Abstract][Full Text] [Related]
59. Is COVID-19 Gender-sensitive?
Mukherjee S; Pahan K
J Neuroimmune Pharmacol; 2021 Mar; 16(1):38-47. PubMed ID: 33405098
[TBL] [Abstract][Full Text] [Related]
60. Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element.
Clinckemalie L; Spans L; Dubois V; Laurent M; Helsen C; Joniau S; Claessens F
Mol Endocrinol; 2013 Dec; 27(12):2028-40. PubMed ID: 24109594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
